102 related articles for article (PubMed ID: 12611459)
21. Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation.
Annab LA; Terry L; Cable PL; Brady J; Stampfer MR; Barrett JC; Afshari CA
Gynecol Oncol; 2000 Apr; 77(1):121-8. PubMed ID: 10739701
[TBL] [Abstract][Full Text] [Related]
22. Vanillin (3-methoxy-4-hydroxybenzaldehyde) inhibits mutation induced by hydrogen peroxide, N-methyl-N-nitrosoguanidine and mitomycin C but not (137)Cs gamma-radiation at the CD59 locus in human-hamster hybrid A(L) cells.
Gustafson DL; Franz HR; Ueno AM; Smith CJ; Doolittle DJ; Waldren CA
Mutagenesis; 2000 May; 15(3):207-13. PubMed ID: 10792012
[TBL] [Abstract][Full Text] [Related]
23. Involvement of cell cycle control in bleomycin-induced mutagen sensitivity.
Cloos J; Temmink O; Ceelen M; Snel MH; Leemans CR; Braakhuis BJ
Environ Mol Mutagen; 2002; 40(2):79-84. PubMed ID: 12203399
[TBL] [Abstract][Full Text] [Related]
24. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
[TBL] [Abstract][Full Text] [Related]
25. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.
Tomlinson GE; Chen TT; Stastny VA; Virmani AK; Spillman MA; Tonk V; Blum JL; Schneider NR; Wistuba II; Shay JW; Minna JD; Gazdar AF
Cancer Res; 1998 Aug; 58(15):3237-42. PubMed ID: 9699648
[TBL] [Abstract][Full Text] [Related]
27. Chromosome loss caused by DNA fragmentation induced in main nuclei and micronuclei of human lymphoblastoid cells treated with colcemid.
Yamamoto M; Wakata A; Aoki Y; Miyamae Y; Kodama S
Mutat Res; 2014 Apr; 762():10-6. PubMed ID: 24582839
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the radioprotective efficacy of hesperidin against gamma-radiation induced cellular damage in cultured human peripheral blood lymphocytes.
Kalpana KB; Devipriya N; Srinivasan M; Menon VP
Mutat Res; 2009 May; 676(1-2):54-61. PubMed ID: 19486865
[TBL] [Abstract][Full Text] [Related]
29. Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation.
Baert A; Depuydt J; Van Maerken T; Poppe B; Malfait F; Storm K; van den Ende J; Van Damme T; De Nobele S; Perletti G; De Leeneer K; Claes KB; Vral A
Breast Cancer Res; 2016 May; 18(1):52. PubMed ID: 27184744
[TBL] [Abstract][Full Text] [Related]
30. Gamma-radiation sensitivity and risk of glioma.
Bondy ML; Wang LE; El-Zein R; de Andrade M; Selvan MS; Bruner JM; Levin VA; Alfred Yung WK; Adatto P; Wei Q
J Natl Cancer Inst; 2001 Oct; 93(20):1553-7. PubMed ID: 11604478
[TBL] [Abstract][Full Text] [Related]
31. Effects of pulsed electric fields on DNA of human lymphocytes.
Delimaris J; Tsilimigaki S; Messini-Nicolaki N; Ziros E; Piperakis SM
Cell Biol Toxicol; 2006 Nov; 22(6):409-15. PubMed ID: 16897439
[TBL] [Abstract][Full Text] [Related]
32. Effect of mangiferin on radiation-induced micronucleus formation in cultured human peripheral blood lymphocytes.
Jagetia GC; Venkatesha VA
Environ Mol Mutagen; 2005 Jul; 46(1):12-21. PubMed ID: 15795888
[TBL] [Abstract][Full Text] [Related]
33. Activation of 3-nitrobenzanthrone and its metabolites to DNA-damaging species in human B lymphoblastoid MCL-5 cells.
Arlt VM; Cole KJ; Phillips DH
Mutagenesis; 2004 Mar; 19(2):149-56. PubMed ID: 14981162
[TBL] [Abstract][Full Text] [Related]
34. Heterocyclic aromatic amines induce DNA strand breaks and cell transformation.
Pfau W; Martin FL; Cole KJ; Venitt S; Phillips DH; Grover PL; Marquardt H
Carcinogenesis; 1999 Apr; 20(4):545-51. PubMed ID: 10223180
[TBL] [Abstract][Full Text] [Related]
35. DNA damage, oxidative mutagen sensitivity, and repair of oxidative DNA damage in nonmelanoma skin cancer patients.
Bendesky A; Michel A; Sordo M; Calderón-Aranda ES; Acosta-Saavedra LC; Salazar AM; Podoswa N; Ostrosky-Wegman P
Environ Mol Mutagen; 2006 Aug; 47(7):509-17. PubMed ID: 16673411
[TBL] [Abstract][Full Text] [Related]
36. Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriers.
Kotsopoulos J; Chen Z; Vallis KA; Poll A; Ghadirian P; Kennedy G; Ainsworth P; Narod SA
Cancer Causes Control; 2010 May; 21(5):679-87. PubMed ID: 20063075
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal instability in mutagen-sensitive mutants isolated from mouse lymphoma L5178Y cells. II. Abnormal induction of sister-chromatid exchanges and chromosomal aberrations by mutagens in an ionizing radiation-sensitive mutant (M10) and an alkylating agent-sensitive mutant (MS1).
Tsuji H; Takahashi E; Tsuji S; Tobari I; Shiomi T; Sato K
Mutat Res; 1987 May; 178(1):107-16. PubMed ID: 3106796
[TBL] [Abstract][Full Text] [Related]
38. Infrared microspectroscopy study of gamma-irradiated and H2O2-treated human cells.
Gault N; Rigaud O; Poncy JL; Lefaix JL
Int J Radiat Biol; 2005 Oct; 81(10):767-79. PubMed ID: 16449084
[TBL] [Abstract][Full Text] [Related]
39. Heterozygote BRCA1 status and skewed chromosome X inactivation.
Helbling-Leclere A; Lenoir GM; Feunteun J
Fam Cancer; 2007; 6(1):153-7. PubMed ID: 16944269
[TBL] [Abstract][Full Text] [Related]
40. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM
Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
